Markets:

Overview

News

Currencies

International

Treasuries

EyePoint, Inc. - Common Stock (NQ:EYPT)

12.94 -0.07 (-0.54%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about EyePoint, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Why EyePoint Pharmaceuticals Shares Are Shooting Higher Today ↗

May 03, 2023

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) reported Q1 revenues of $7.68 million, down from $9.3 million a year ago but slightly

Via Benzinga

EyePoint Pharmaceuticals: Q1 Earnings Insights ↗

May 03, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 24, 2023

Via Benzinga

Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 24, 2023

Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.

Via Benzinga

Earnings Preview: EyePoint Pharmaceuticals ↗

March 01, 2023

Via Benzinga

EyePoint Pharma Posts 12-Month Safety, Efficacy Data From Early-Stage Wet AMD Trial ↗

July 15, 2022

Via Benzinga

Chardan Forecasts Over 160% Upside On This Eye Disease-Focused Stock ↗

July 07, 2022

Via Benzinga

Super Micro Computer, Garrett Motion, Rackspace Technology And Other Big Stocks Moving Lower On Monday ↗

April 24, 2023

U.S. stocks traded mixed, with the Nasdaq Composite dropping around 50 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Nasdaq Edges Higher; Procter & Gamble Posts Upbeat Earnings ↗

April 21, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite edging higher on Friday. The Dow traded down 0.06% to 33,765.47 while the NASDAQ rose 0.02% to 12,062.18. The S&P 500, also...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 21, 2023

Via Benzinga

Gold Down Over 1%; US Composite PMI Rises In April ↗

April 21, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 70 points on Friday. The Dow traded down 0.20% to 33,718.74 while the NASDAQ fell 0.33% to 12,019.40. The S&P 500,...

Via Benzinga

Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 21, 2023

Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.

Via Benzinga

US Stocks Mostly Lower; Nasdaq Down 50 Points ↗

April 21, 2023

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 50 points on Friday. Following the market opening Friday, the Dow traded down 0.03% to 33,777.38 while the NASDAQ...

Via Benzinga

Finance Executives Look For Ways To Diversify Cash Strategies After Silicon Valley Bank's Fallout ↗

March 16, 2023

Financial officers at companies with money held at Silicon Valley Bank (NASDAQ: SIVB) are re-evaluating their cash-management strategies.

Via Benzinga

EyePoint Pharma Posts Deeper Losses For Q4, Expects Cash Runway Into 2024 ↗

March 02, 2023

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has reported Q4 revenues of $10.5 million, down 8.8% Y/Y, almost in line with the consensus of $10.40 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 03, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 12, 2023

Via Benzinga

AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials ↗

November 14, 2022

Visit https://www.startengine.com/aiviva to invest in AiViva’s StartEngine Campaign.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

November 30, 2022

During Wednesday's session, 107 stocks hit new 52-week lows.

Via Benzinga

EyePoint Pharmaceuticals: Q3 Earnings Insights ↗

November 02, 2022

EyePoint Pharmaceuticals (NASDAQ:EYPT) reported its Q3 earnings results on Wednesday, November 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Meet The Company Bringing New Treatments For Serious Eye Issues To Market ↗

October 05, 2022

Via Benzinga

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial ↗

August 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Recap: EyePoint Pharmaceuticals Q2 Earnings ↗

August 03, 2022

EyePoint Pharmaceuticals (NASDAQ:EYPT) reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 05, 2022

Wednesday saw 127 companies set new 52-week lows.

Via Benzinga

Earnings Preview For EyePoint Pharmaceuticals ↗

August 02, 2022

EyePoint Pharmaceuticals (NASDAQ:EYPT) is set to give its latest quarterly earnings report on Wednesday, 2022-08-03. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Recap of Monday's Biotech Catalysts - End of the Day Summary ↗

July 18, 2022

Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least...

Via Benzinga

Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday ↗

July 18, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 15, 2022

Via Benzinga

EyePoint Announces Positive Safety and Efficacy Data From Initial-Stage Wet AMD Study ↗

July 15, 2022

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) announced 12-month data readout from the Phase 1 DAVIO clinical trial evaluating EYP-1901, targeting wet age-related macular degeneration (wet AMD) as a...

Via Benzinga

7 Wildly Oversold Nasdaq Stocks to Buy Now ↗

July 12, 2022

For speculators that are seeking the next big upside opportunity, you may consider these oversold Nasdaq stocks to buy now.

Via InvestorPlace

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

EyePoint, Inc. - Common Stock (NQ:EYPT)

Headline News about EyePoint, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today